new YORK (Reuters Health) – when the smokers than

are using nicotine patches suffer a relapse,

they would be more likely to not return to smoking if they continue using

these elements rather than abandon treatment, determined

a new study.

A team returned to analyze the results of a study

on the effectiveness of nicotine in smoking patches of

United States. The review included 509 participants that

had a relapse from the third to the fifth week of

treatment. (Means “ relapse” just smoking a

)(

cigarette).

The authors noted that users of the patches were

more likely than placebo ( control group) users to

“recovering”, i.e. return to quit smoking between the sixth

and the tenth week of treatment (8 percent versus less of the

1 per cent in the control group).

“The effect is not very great.” “Does not leave us with the mouth

Open”, said Dr. Norman H. Edelman, medical director

of the American Association of the lungs and not

he participated in the study, published in Addiction.

The specialist said that the study had limitations,

as a “secondary” analysis of a clinical trial that not

was designed to respond if adhering to therapies of

nicotine replacement improves recovery from relapses.

In addition, the study was funded by GlaxoSmithKline,

to produce the Nicoderm CQ patch and other therapies for replacement,

while the members of the team of Stuart Ferguson, of

the University of Tasmania, Australia, are consultants of the

pharmaceutical.

Edelman explained that the nicotine replacement therapies

help to stop smoking. With regard to the utility of continuing the

use of the patches after a relapse, said that there is

“a grey area”.

There is the concern that patients who smoke

while using the patch might suffer from an overdose of

nicotine. But the team Ferguson writes that some

studies found that holding therapy despite a relapse

would have “a small additional risk” adverse effects.

Hillel r. Alpert, researcher at the Center for the Control

World of the tobacco of the Faculty of public health from Harvard,

it considered that one of the main limitations of the study

which focused on results in the short term. “Does not tell us

what about abstinence in the long-term”, said Alpert.

A month ago, the Alpert team published the results of

a study “in the real world”. There, concluded that the therapy of

nicotine replacement would not be as effective in the long

period.

“Is important to have a support program that allows

“”

change the mentality and habits”, said Edelman. Even so,

quit smoking is a battle.

“A smoker performs five to six attempts before

“”

finally quit”, said Edelman.

Source: Addiction, online January 26, 2012.